Get the Stockscreener App
0.218
5.46%
-0.0126
After Hours:
.22
0.002
+0.92%
Klotho Neurosciences Inc stock is traded at $0.218, with a volume of 569.29K.
It is down -5.46% in the last 24 hours and down -35.66% over the past month.
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.
See More
Previous Close:
$0.2306
Open:
$0.23
24h Volume:
569.29K
Relative Volume:
0.82
Market Cap:
$15.81M
Revenue:
-
Net Income/Loss:
$-11.35M
P/E Ratio:
-0.4787
EPS:
-0.4554
Net Cash Flow:
$-5.51M
1W Performance:
-1.22%
1M Performance:
-35.66%
6M Performance:
-73.00%
1Y Performance:
-36.13%
1-Day Range:
$0.2111
$0.2374
1-Week Range:
$0.2111
$0.2576
52-Week Range:
$0.1135
$3.9099
Klotho Neurosciences Inc Stock (KLTO) Company Profile
Name
Klotho Neurosciences Inc
Sector
Industry
Phone
(833) 931-6330
Address
13576 WALNUT STREET, SUITE A, OMAHA
Compare KLTO vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KLTO
Klotho Neurosciences Inc
|
0.218 | 16.73M | 0 | -11.35M | -5.51M | -0.4554 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Klotho Neurosciences Inc Stock (KLTO) Latest News
Institution Moves: Can DNUT grow without external fundingWeekly Market Summary & Daily Technical Stock Forecast Reports - baoquankhu1.vn
Rally Mode: Is Klotho Neurosciences Inc gaining market shareTrend Reversal & Safe Capital Preservation Plans - baoquankhu1.vn
Hedge Fund Bets: Is Klotho Neurosciences Inc Equity Warrant affected by consumer sentimentTrade Volume Report & Free Community Consensus Stock Picks - baoquankhu1.vn
Momentum Shift: What is the PEG ratio of Klotho Neurosciences Inc Equity WarrantJuly 2025 Volume & Scalable Portfolio Growth Methods - baoquankhu1.vn
What’s the beta of Klotho Neurosciences Inc. stock2025 Risk Factors & Real-Time Volume Surge Alerts - mfd.ru
Whats the beta of Klotho Neurosciences Inc stockWeekly Market Report & High Return Trade Opportunity Guides - baoquankhu1.vn
Retail Trends: Is XOMA stock showing strong momentumMarket Trend Summary & AI Enhanced Execution Alerts - baoquankhu1.vn
KLTOW SEC FilingsKlotho Neurosciences, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
CEO Change: Is Klotho Neurosciences Inc Equity Warrant affected by consumer sentimentJuly 2025 Analyst Calls & Low Drawdown Trading Techniques - baoquankhu1.vn
Is Klotho Neurosciences Inc. stock attractive for passive investorsQuarterly Market Summary & High Win Rate Trade Alerts - bollywoodhelpline.com
CEO Change: Is Klotho Neurosciences Inc gaining market shareJuly 2025 Rallies & Weekly Sector Rotation Insights - baoquankhu1.vn
Bear Alert: Is Steven Madden Ltd attractive for institutional investors2025 Market Trends & Community Consensus Trade Signals - baoquankhu1.vn
Weekly Earnings: Should I add Klotho Neurosciences Inc stock to my portfolioPortfolio Risk Summary & AI Forecast Swing Trade Picks - baoquankhu1.vn
Highs Report: Is Klotho Neurosciences Inc Equity Warrant affected by consumer sentimentWeekly Risk Report & Consistent Profit Trade Alerts - baoquankhu1.vn
Hedge Fund Moves: What is HIHOs TAM Total Addressable MarketQuarterly Portfolio Report & Safe Capital Growth Trade Ideas - baoquankhu1.vn
Fed Watch: Is Klotho Neurosciences Inc forming a breakout pattern2025 Fundamental Recap & Intraday High Probability Alerts - baoquankhu1.vn
S P Trends: What is the PEG ratio of Klotho Neurosciences Inc Equity Warrant2025 Price Action Summary & Daily Profit Maximizing Trade Tips - baoquankhu1.vn
ETF Watch: What are analysts price targets for Klotho Neurosciences IncWeekly Trading Summary & Precise Buy Zone Identification - baoquankhu1.vn
Earnings Beat: Is Palo Alto Networks Incs ROIC above industry averageGDP Growth & Daily Growth Stock Investment Tips - baoquankhu1.vn
Aug Momentum: What are analysts price targets for Klotho Neurosciences IncProfit Target & Step-by-Step Swing Trade Plans - baoquankhu1.vn
What dividend safety score for Klotho Neurosciences Inc. Equity Warrant stockJuly 2025 Drop Watch & Smart Investment Allocation Insights - Улправда
Can Klotho Neurosciences Inc. stock beat analyst upgrades2025 Growth vs Value & Reliable Breakout Stock Forecasts - Улправда
Klotho Neurosciences to Present at the Biotech Showcase 2026 - Sahm
Why Klotho Neurosciences Inc. stock could rally in 2025July 2025 Analyst Calls & Real-Time Volume Analysis - Улправда
Is Klotho Neurosciences Inc. stock a top momentum playJuly 2025 Opening Moves & Stock Portfolio Risk Management - Улправда
Is Klotho Neurosciences Inc. stock recession proofJuly 2025 Sector Moves & Low Risk High Reward Ideas - ulpravda.ru
Can Klotho Neurosciences Inc. stock beat market expectations this quarterWeekly Trade Report & Verified Technical Signals - Улправда
Will Klotho Neurosciences Inc. Equity Warrant stock recover faster than peersMarket Activity Summary & Community Verified Swing Trade Signals - Улправда
Will Klotho Neurosciences Inc. stock benefit from sector rotationMarket Performance Recap & High Conviction Trade Alerts - Улправда
How Klotho Neurosciences Inc. Equity Warrant stock compares to growth peersJuly 2025 Short Interest & Free Real-Time Market Sentiment Alerts - Улправда
Coinbase CEO Brian Armstrong Says His Biotech Company Is Working On 'Extending' Human Lifespan: Here Is How They Plan To Do It - Benzinga
Klotho Neurosciences, Inc. (KLTOW) Stock Forecast & Price Prediction 2025–2030 - CoinCodex
What analysts say about Klotho Neurosciences Inc Equity Warrant stockVolume Spike Alerts & Affordable Trading Plans - earlytimes.in
Rate Cut: Is Klotho Neurosciences Inc stock a dividend growth opportunity2025 Trading Recap & Free Weekly Watchlist of Top Performers - Bộ Nội Vụ
Will Klotho Neurosciences Inc. stock benefit from AI adoption2025 Market Outlook & Accurate Entry and Exit Point Alerts - Улправда
How interest rate cuts could boost Klotho Neurosciences Inc. Equity Warrant stockJuly 2025 Setups & Technical Pattern Alert System - Улправда
Will Klotho Neurosciences Inc. stock outperform value stocks2025 Analyst Calls & Technical Pattern Based Signals - Улправда
How Klotho Neurosciences Inc. stock reacts to job market dataMarket Trend Report & Daily Momentum Trading Reports - Улправда
How sustainable is Klotho Neurosciences Inc. Equity Warrant stock dividend payout2025 Fundamental Recap & Stock Portfolio Risk Management - DonanımHaber
Klotho Neurosciences, Inc. Warrant 2024-21.06.29 on Klotho Neuroscience - TradingView — Track All Markets
Can Klotho Neurosciences Inc. stock weather global recessionJuly 2025 Review & Fast Entry Momentum Alerts - Улправда
Is Klotho Neurosciences Inc. Equity Warrant stock a buy for dividend growthJuly 2025 Gainers & Free Weekly Chart Analysis and Trade Guides - DonanımHaber
How Klotho Neurosciences Inc. Equity Warrant stock compares to market leaders2025 Market Overview & Community Trade Idea Sharing - ulpravda.ru
Beyond Weight Loss: The "Cellular Reset" That Could Create the Next Biotech Supercycle - The Globe and Mail
Klotho Neurosciences enters securities purchase agreement - MSN
Klotho Neurosciences enters agreement to sell Series C preferred stock to Sigma9 Capital - Investing.com Australia
Klotho Neurosciences Inc Stock (KLTO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.24%
0.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):